Clinical Trial Update: Montelukast for Early Life Wheezing [Phase 2, Phase 3]

View source ↗

Summary

Montelukast has completed Phase 2 and Phase 3 trials for early-life wheezing; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)
• SINGULAIR (montelukast)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Lung Diseases, Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-02-06